AIDS vaccine

The vaccine will be available at low cost in 120 poor countries. But nearly all of Latin America was excluded from a deal with the drug's manufacturer, Gilead.

An oversight committee halted a big clinical study of an experimental HIV vaccine after a peek at preliminary results showed there was no way the study would be able show the vaccine works. More vaccinated people became infected with HIV than those who got placebo shots.